A detailed history of Meiji Yasuda Life Insurance CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 31,232 shares of LLY stock, worth $24.9 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
31,232
Previous 32,299 3.3%
Holding current value
$24.9 Million
Previous $29.2 Million 5.38%
% of portfolio
0.51%
Previous 0.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $823,873 - $1.02 Million
-1,067 Reduced 3.3%
31,232 $27.7 Million
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $499,435 - $626,328
-689 Reduced 2.09%
32,299 $29.2 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $2.54 Million - $3.4 Million
4,295 Added 14.97%
32,988 $25.7 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $2.7 Million - $3.18 Million
5,132 Added 21.78%
28,693 $16.7 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $2.28 Million - $3.15 Million
5,248 Added 28.66%
23,561 $12.7 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $141,348 - $188,998
-403 Reduced 2.15%
18,313 $8.59 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $1.04 Million - $1.23 Million
3,358 Added 21.86%
18,716 $6.43 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $41,801 - $48,707
-130 Reduced 0.84%
15,358 $5.62 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1.19 Million - $1.35 Million
4,000 Added 34.82%
15,488 $5.01 Million
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $917,300 - $1.08 Million
3,291 Added 40.15%
11,488 $3.73 Million
Q1 2022

May 17, 2022

SELL
$234.69 - $291.66 $199,721 - $248,202
-851 Reduced 9.41%
8,197 $2.35 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $34,402 - $42,693
153 Added 1.72%
9,048 $2.5 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $157,779 - $194,169
-712 Reduced 7.41%
8,895 $2.06 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $194,452 - $251,522
-1,077 Reduced 10.08%
9,607 $2.21 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $157,747 - $204,211
-960 Reduced 8.24%
10,684 $2 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $254,657 - $336,973
-1,952 Reduced 14.36%
11,644 $1.97 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $63,167 - $73,064
432 Added 3.28%
13,596 $2.01 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $54,158 - $65,179
-397 Reduced 2.93%
13,164 $2.16 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $182,741 - $226,182
1,535 Added 12.76%
13,561 $1.88 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $38,491 - $47,674
-360 Reduced 2.91%
12,026 $1.58 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $88,849 - $96,645
832 Added 7.2%
12,386 $1.39 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $178,704 - $208,593
-1,613 Reduced 12.25%
11,554 $1.28 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $197,018 - $231,905
-1,770 Reduced 11.85%
13,167 $1.71 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $63,540 - $71,184
-600 Reduced 3.86%
14,937 $1.73 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $65,253 - $81,555
-760 Reduced 4.66%
15,537 $1.67 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $56,775 - $65,160
750 Added 4.82%
16,297 $1.39 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $28,199 - $33,288
380 Added 2.51%
15,547 $1.2 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $175,351 - $188,084
-2,140 Reduced 12.36%
15,167 $1.28 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $1.33 Million - $1.48 Million
17,307
17,307 $1.48 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meiji Yasuda Life Insurance CO Portfolio

Follow Meiji Yasuda Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.